Sign in

CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870419387
Phone
310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Open-market buy Chairman and CEO bought 1,900 shares at $1.29 ($2,451)
  2. NT 10-Q Other NT 10-Q
  3. NT 10-K Other NT 10-K
  4. 4 Open-market buy Chairman and CEO bought 5,300 shares at an average $1.30 ($6,870)
  5. 4 Open-market buy Chairman and CEO bought 7,850 shares at an average $1.26 ($9,911)
  6. 4 Open-market buy Chairman and CEO bought 4,000 shares at an average $1.32 ($5,260)
  7. 4 Open-market buy Chairman and CEO bought 8,000 shares at an average $1.24 ($9,890)
  8. 8-K/A Event Other events
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Chairman and CEO bought 17,300 shares at an average $1.68 ($29,021)
  11. 4 Open-market buy Chairman and CEO bought 9,900 shares at an average $1.29 ($12,736)
  12. 4 Open-market buy Chairman and CEO bought 13,000 shares at an average $1.25 ($16,235)
  13. 4 Open-market buy Chairman and CEO bought 30,800 shares at an average $1.26 ($38,784)
  14. 4 Open-market buy Chairman and CEO bought 13,200 shares at $1.21 ($15,972)
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 4 Open-market buy Vice Chairman & COO bought 4,500 shares at an average $1.26 ($5,665)
  17. 8-K Event Executive or director change
  18. 4 Open-market buy Chairman and CEO bought 19,200 shares at an average $1.11 ($21,364)
  19. 4 Open-market buy Vice Chairman & COO bought 6,800 shares at an average $1.14 ($7,770)
  20. 8-K Event Other events

Page 14 of 63 · 1,250 filings